Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention

• Published in: Journal of the American College of Cardiology Vol. 40; no. 4; pp. 669 - 675
• Main Authors: Chan, Albert W, Quinn, Martin J, Bhatt, Deepak L, Chew, Derek P, Moliterno, David J, Topol, Eric J, Ellis, Stephen G
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 21.08.2002; Elsevier Science; Elsevier Limited
• Subjects: Adrenergic beta-Antagonists - therapeutic use; Aged; Angioplasty, Balloon, Coronary; Biological and medical sciences; Cardiology; Coronary Disease - drug therapy; Coronary Disease - mortality; Coronary Disease - therapy; Coronary vessels; Diseases of the cardiovascular system; Drug therapy; Elective Surgical Procedures; Female; Heart attacks; Humans; Male; Medical sciences; Middle Aged; Mortality; Multivariate Analysis; Prospective Studies; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Survival Analysis; United States > US; ACE; CI; CAD; PCI; CK; LVEF; CABG; MI; COPD; Human; Prognosis; Treatment efficiency; Mortality; Coronary artery; Instrumentation therapy; Long term; Morbidity; β-Adrenergic receptor; Chemotherapy; Treatment; Antagonist; Comparative study; Beta blocking agent

The goal of this study was to evaluate the mortality benefit of beta-blockers after successful percutaneous coronary intervention (PCI). Beta-blockers reduce mortality after myocardial infarction (MI), though limited data are available regarding their role after successful PCI. Each year from 1993 t...